Skip to main navigation
Loading
  • News
  • Investors
  • Careers
  • Contact
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

Events & Presentations

  • Overview
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Press Releases
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • IRS – Required Disclosures
  • SEC Filings
    • Quarterly Results
  • Contact
  • Email Alerts

Company Presentation

  • Zevra Therapeutics Corporate Presentation – September 2023

    09-13-2023

  • Zevra Corporate Update – Acer Therapeutics Acquisition

    08-31-2023

Upcoming Events

More events are coming soon.

Past Events

Cantor Global Healthcare Conference
09-27-2023 3:00 PM EDT
Listen to webcast
H.C. Wainwright 25th Annual Global Investment Conference
09-13-2023 8:30 AM EDT
Listen to webcast
H.C. Wainwright 25th Annual Global Investment Conference Presentation 5.6 MB
Zevra Therapeutics corporate update call to announce the acquisition of Acer Therapeutics
08-31-2023 8:30 AM EDT
Listen to webcast

The dial in and link information is below.

Participant Toll-Free Number: 800-245-3047 Primary
Participant Direct/International Number: 203-518-9765 Alternate
Conference ID: ZevraUpdate

Zevra Therapeutics Q2 2023 Earnings Call
08-14-2023 8:30 AM EDT
Listen to webcast
Zevra Quarterly Results Presentation – Q2 2023 Results 4.8 MB
Maxim Virtual Healthcare Conference
06-22-2023 from 9:30 AM to 9:55 AM EDT
Listen to webcast
This conference will be live on M-Vest. To attend, investors can register and watch the company discussion on the M-Vest page: https://m-vest.com/insights/marketpulse/healthcare-virtual-conference-2023-replays. 
RBC 2023 Global Healthcare Conference
05-16-2023 3:05 PM EDT
Listen to webcast
Zevra Therapeutics Q1 2023 Earnings Call
05-15-2023 4:30 PM EDT
Listen to webcast
Roth Capital Partners 35th Annual Roth Conference
03-13-2023
Listen to webcast
Zevra Therapeutics Q4 and FY 2022 Earnings Call
03-07-2023 8:30 AM EST
Listen to webcast
Zevra Quarterly Results Presentation – Q4 and FY 2022 Results 1.8 MB
KemPharm Quarterly Results Transcript – Q4 2022 212.1 KB
KemPharm Q3 2022 Corporate Update Call
11-09-2022 5:00 PM EST
Listen to webcast
KemPharm Quarterly Results Presentation – Q3 2022 1.8 MB
KemPharm Quarterly Results Transcript – Q3 2022 136.9 KB
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use

Scroll to top